• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA II DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-Q180V
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Unspecified Infection (1930); Sepsis (2067)
Date of Event 08/11/2020
Type of Reportable Event Serious Injury
Event or Problem Description
The customer reported to olympus the evis exera ii duodenovideoscope was a scope of potential infection after being notified by the maine center for disease control (cdc) that they were dealing with a carbapenem-resistant enterobacterial (cre) organism.The scope of concern was cultured by the customer on (b)(6) 2020, (b)(6) 2021, (b)(6) 2021, and (b)(6) 2021.On (b)(6) 2021 the scope was tested after a known cre case.The scope tested negative after each culture on (b)(6) 2020, (b)(6) 2021, (b)(6) 2021, and (b)(6) 2021.The epidemiologist was made aware of a cluster of patients that were infected over 1 year ago with carbapenem-resistant enterobacteriaceae (highly resistant cp-cre organism).A "few patients" tested positive; however, reprocessing department was never informed.The reprocessing department was instructed to pull the device out of service on (b)(6) 2021.The device was cultured on (b)(6) 2021.The culture was done after the device had been disinfected numerous times as the patient infection occurred in (b)(6) 2020.The device culture was negative.The customer further reported that they had three patients who had been examined by this particular scope and were genetically identical e.Cloacae.This complaint is for patient 2, a (b)(6) year old female weighing (b)(6) kilograms with a medical history of pneumonia, hypertension, hypothyroidism, paroxysmal atrial fibrillation, and peptic ulcer disease.The patient was scoped with the subject device for biliary obstruction and cholangioca (b)(6) 2020 and (b)(6) 2020.The patient was later diagnosed with sepsis after her blood was cultured and tested positive for kpc-e.Cloacae on (b)(6) 2021.The patient received iv antibiotics for sepsis and her current status is reported as living.Patient identifier (b)(6) is for patient 1 of 3.Patient identifier (b)(6) is for patient 3 of 3.This complaint is for patient identifier (b)(6) for patient 2 of 3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II DUODENOVIDEOSCOPE
Common Device Name
DUODENOVIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key12557860
Report Number2951238-2021-00421
Device Sequence Number1167398
Product Code FDT
UDI-Device Identifier04953170229503
UDI-Public04953170229503
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Type of Report Initial
Report Date (Section B) 09/30/2021
Report Date (Section F) 09/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberTJF-Q180V
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2021
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date09/24/2021
Event Location Hospital
Date Report to Manufacturer09/24/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date09/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age73 YR
Patient Weight85
-
-